These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9735117)

  • 1. HIV infection and AIDS.
    Shearer WT
    Prim Care; 1998 Dec; 25(4):759-74. PubMed ID: 9735117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV immunotherapy comes of age: implications for prevention, treatment and cure.
    Routy JP; Mehraj V; Cao W
    Expert Rev Clin Immunol; 2016; 12(2):91-4. PubMed ID: 26629806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate vaccines for immunotherapy in HIV.
    Gotch FM; Imami N; Hardy G
    HIV Med; 2001 Oct; 2(4):260-5. PubMed ID: 11737407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing AIDS but not HIV-1 infection with a DNA vaccine.
    Shen X; Siliciano RF
    Science; 2000 Oct; 290(5491):463-5. PubMed ID: 11183769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan L; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL
    Science; 2000 Oct; 290(5491):486-92. PubMed ID: 11039923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune.
    Angel JB; Routy JP; Tremblay C; Ayers D; Woods R; Singer J; Bernard N; Kovacs C; Smaill F; Gurunathan S; Sekaly RP
    AIDS; 2011 Mar; 25(6):731-9. PubMed ID: 21330911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS vaccines. Immune Response Corp.--take two.
    Cohen J
    Science; 1994 Jun; 264(5164):1402. PubMed ID: 7910980
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS therapy. Failure isn't what it used to be...but neither is success.
    Cohen J
    Science; 1998 Feb; 279(5354):1133-4. PubMed ID: 9508685
    [No Abstract]   [Full Text] [Related]  

  • 10. Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy.
    Gougeon ML; Montagnier L
    Ann N Y Acad Sci; 1999; 887():199-212. PubMed ID: 10668476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic HIV vaccines show promise.
    Abbott A
    Nature; 2010 Jul; 466(7306):539. PubMed ID: 20671679
    [No Abstract]   [Full Text] [Related]  

  • 12. International AIDS meeting injects a dose of realism.
    Balter M; Cohen J
    Science; 1998 Jul; 281(5374):159-60. PubMed ID: 9687273
    [No Abstract]   [Full Text] [Related]  

  • 13. Modeling interleukin-2-based immunotherapy in AIDS pathogenesis.
    Joly M; Odloak D
    J Theor Biol; 2013 Oct; 335():57-78. PubMed ID: 23806696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on inducing efficient immune control of HIV-1 replication--a new goal for HIV therapeutics?
    Bucy RP; Kilby JM
    AIDS; 2001 Feb; 15 Suppl 2():S36-42. PubMed ID: 11424975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.
    Notermans DW; Pakker NG; Hamann D; Foudraine NA; Kauffmann RH; Meenhorst PL; Goudsmit J; Roos MT; Schellekens PT; Miedema F; Danner SA
    J Infect Dis; 1999 Oct; 180(4):1050-6. PubMed ID: 10479130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of T-cell immunity to antiretroviral drug-resistant human immunodeficiency virus type 1.
    Stratov I; Dale CJ; Chea S; McCluskey J; Kent SJ
    J Virol; 2005 Jun; 79(12):7728-37. PubMed ID: 15919925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical management of acute and chronic human immunodeficiency virus infection before starting antiretroviral treatment].
    Miró JM; Manzardo C; Zamora L; Pumarola T; Herreras Z; Gallart T; Gatell JM
    Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):759-72. PubMed ID: 22078726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
    Oxenius A; Price DA; Dawson SJ; Günthard HF; Fischer M; Perrin L; Ramirez E; Fagard C; Hirschel B; Scullard G; Weber JN; McLean AR; Phillips RE;
    AIDS; 2002 Nov; 16(17):2317-22. PubMed ID: 12441804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evolution and Diversity of HIV-1].
    Metzner KJ
    Praxis (Bern 1994); 2011 Jan; 100(1):29-35. PubMed ID: 21210358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.